Uzliv 500 is a potent hepatoprotective medication manufactured by MK Healthcare, containing Ursodeoxycholic Acid (UDCA) 500mg. This naturally occurring bile acid plays a crucial role in maintaining liver health by reducing the amount of cholesterol produced by the liver and dissolving cholesterol-based gallstones. It is widely prescribed for patients suffering from primary biliary cirrhosis and other cholestatic liver diseases, providing a non-surgical approach to managing gallbladder and bile duct health.

The primary mechanism of Uzliv 500 involves improving the flow of bile and protecting liver cells from the toxic effects of accumulated bile acids. By lowering the cholesterol saturation index in the bile, it facilitates the gradual dissolution of small, radiolucent gallstones, preventing the need for invasive procedures in eligible candidates. Furthermore, it helps stabilize liver membranes and reduces inflammation, making it an essential therapy for those with chronic liver conditions.

Regular use of Uzliv 500 tablets can significantly improve liver function tests by lowering elevated levels of liver enzymes such as ALT and AST. This makes it a vital component in the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) and various forms of hepatitis where bile stasis is a concern. MK Healthcare ensures the highest quality standards in the formulation of Uzliv 500, ensuring maximum bioavailability and therapeutic efficacy for patients requiring long-term liver support.

As a high-strength 500mg UDCA tablet, Uzliv 500 offers a convenient dosage regimen for patients. While generally well-tolerated, it is recommended to take this medication under strict medical supervision, usually with food to enhance absorption. Whether used for the management of biliary sludge or the prevention of gallstone formation during rapid weight loss, Uzliv 500 stands as a trusted pharmaceutical solution for comprehensive hepatobiliary care.